Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optikon is a prominent Italian medical device company dedicated to the field of ophthalmology, specializing in both diagnostic and surgical solutions. Founded in 1966 and headquartered in Rome, the company designs and manufactures high-precision equipment including phacoemulsification systems, vitrectomes, and corneal topographers. Their flagship R-Evolution platform provides surgeons with advanced fluidics and cutting capabilities for anterior and posterior segment surgeries. Additionally, the Keratron line of topographers is widely regarded for its accuracy in mapping corneal curvature and diagnosing conditions like keratoconus. Optikon maintains a global presence, distributing its ISO-certified technology to clinics and hospitals worldwide to improve patient outcomes in vision care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optikon.